Evidence map›Paper›PMID 40500334›Full record

ArticleNPJ digital medicine2025

Real-time digital intervention on oral pre-exposure prophylaxis adherence among MSM: randomized controlled trial.

Zhen-Xing Chu, Xia Jin, Ze-Hao Ye, Yan-Yan Zhu, Xiao-Jie Huang, Hui Wang, Yao-Kai Chen, Yu-Jing An, Zhen-Hao Wu, Yong-Jun Jiang and 2 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zhen-Xing Chu *State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, NHC Key Laboratory of AIDS Prevention and Treatment, National Clinical Research Centre for Laboratory Medicine, The First Hospital of China Medical University, China Medical University, Shenyang, 110001, China.
Xia Jin *Parexel International, Real World Research, 100020, Beijing, China.
Ze-Hao Ye *Department of STD and HIV/AIDS Control and Prevention, Ningbo Municipal Centre for Disease Control and Prevention, Ningbo, 315010, China.
Yan-Yan Zhu *State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, NHC Key Laboratory of AIDS Prevention and Treatment, National Clinical Research Centre for Laboratory Medicine, The First Hospital of China Medical University, China Medical University, Shenyang, 110001, China.
Xiao-Jie HuangCentre for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, 100069, Beijing, China.
Hui WangDepartment of Infectious Diseases, National Clinical Centre for Infectious Diseases, Third People's Hospital of Shenzhen (Second Affiliated Hospital of Southern University of Science and Technology), Shenzhen, 518112, China.
Yao-Kai ChenDepartment of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, China.
Yu-Jing AnState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, NHC Key Laboratory of AIDS Prevention and Treatment, National Clinical Research Centre for Laboratory Medicine, The First Hospital of China Medical University, China Medical University, Shenyang, 110001, China.
Zhen-Hao WuState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, NHC Key Laboratory of AIDS Prevention and Treatment, National Clinical Research Centre for Laboratory Medicine, The First Hospital of China Medical University, China Medical University, Shenyang, 110001, China.
Yong-Jun JiangState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, NHC Key Laboratory of AIDS Prevention and Treatment, National Clinical Research Centre for Laboratory Medicine, The First Hospital of China Medical University, China Medical University, Shenyang, 110001, China.
Qing-Hai HuState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, NHC Key Laboratory of AIDS Prevention and Treatment, National Clinical Research Centre for Laboratory Medicine, The First Hospital of China Medical University, China Medical University, Shenyang, 110001, China. qhhu@cmu.edu.cn.
Hong ShangState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, NHC Key Laboratory of AIDS Prevention and Treatment, National Clinical Research Centre for Laboratory Medicine, The First Hospital of China Medical University, China Medical University, Shenyang, 110001, China. hongshang100@hotmail.com.

Funding

National Natural Science Foundation of China (NSFC) 82473696Project of Department of Science and Technology of Liaoning Province 2024JH6/100800001
6 · The paper itself

Abstract

Oral pre-exposure prophylaxis (PrEP) effectively prevents HIV among men who have sex with men, but its adherence faces significant hindrances. We evaluated the effectiveness of real-time digital intervention in promoting oral PrEP adherence through a randomized controlled trial using electronic medication monitors. The trial was registered on the Chinese Clinical Trial Registry (ChiCTR1900025604) and randomized 442 MSM to intervention (247) or control group (195). At the 6-month follow-up, the intervention group exhibited significantly higher oral PrEP adherence than the control (83.1% vs. 59.8%; adjusted net difference: 21.0%, 95% confidence interval: 12.9-29.2%, p < 0.001), while no differences were detected in the number of male sexual partners, condomless anal intercourse prevalence, or substance use disorder, with consistent results across both daily and event-driven oral PrEP regimens. Therefore, digital intervention significantly increased oral PrEP adherence over 6 months in the daily and event-driven subgroups but demonstrated no effect on high-risk behaviors.

Identifiers

PMID40500334
PMCPMC12159155

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.